Kakao Healthcare Establishes a Japanese corporation to target the blood sugar management and diet market in earnest through localization
May 16, 2025
|
Former (former) CEO of J-Fax Co., Ltd. Lee Jin-ho was appointed as the first president of the corporation. The head of this corporation is JapaneseHe is an expert who graduated from the Department of Commerce at the University and has about 30 years of experience in promoting Japanese B2C business and IT-related businesses at Hyosung Corporation, Cyberd Korea Corporation, and Global Tax Free Corporation.
Kakao Healthcare is also hiring talented people in sales, marketing, planning, and development, including local medical staff, and plans to conclude this contract and partnership with global and local partners as early as the first half of the year.
Kakao Healthcare, which has been seeking to develop overseas markets such as Japan, the Middle East, and the United States since its inception, chose Japan as its first country to enter. According to the International Diabetes Federation (IDF), the number of diabetic patients in Japan in 2021 is estimated to be about 11 million, twice the number in the country, and about 20 million in the pre-diabetes stage. As a result, the need for innovative biosensors and digital healthcare solutions is increasing, and it is judged that the marketability is sufficient.
First, we target the Japanese market with an AI-based mobile health care solution 'PASTA'. While it has been recognized for its expertise and technology as a blood sugar management solution for one year since its launch in February last year, it plans to provide localized services to the Japanese diabetic population.
It will also promote projects targeting hospitals, examination centers, and local governments as well as general consumers. In addition, it plans to target the Japanese diet market with the weight management service 'Pinoert', which was newly launched in pasta earlier this month.
Currently, pasta is being localized by reflecting the characteristics and cultural environment of Japanese users. It is developing health content suitable for the Japanese market and upgrading food databases and AI services. The Japanese version of pasta will be tested in pilot by August and will begin its full-fledged service in September.
Hwang Hee, CEO of Kakao Healthcare, said, "The entry into the Japanese market is the first step for Kakao Healthcare to enter the global market, and based on its proven service competitiveness in Korea, we will provide customized blood sugar management experience optimized for Japanese consumers. We will continue to improve our services and expand our local partnership to successfully settle in the Japanese market."
This article was translated by Naver AI translator.
